Xolair Sales Data
| Rank 93 | Current sales rank, all U.S. Pharmaceuticals. |
Last updated: May 2013 (updated quarterly).
The following data shows Xolair U.S. retail sales in Q1 2013 compared to previous quarters.
| Date Range | Sales Rank | Sales ($000) | Units (000) | ||
|---|---|---|---|---|---|
| Q1 2013 | 93 ( 2) |
$182,221 | -0.33% | 276 | -0.72% |
| Q4 2012 | 91 | $182,829 | -0.81% | 278 | -4.79% |
| Q3 2012 | 91 ( ) |
$184,317 |  |
292 | |
* Units refer to the number of packages sold.
Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.
See Also
Related News
| Date | Article |
|---|---|
| March 21, 2011 | Allergy Drug May Speed Up Kids' Ability to Tolerate Milk |
| July 17, 2009 | FDA Reviewing Preliminary Safety Information on Asthma Drug Xolair |
| July 16, 2009 | FDA Investigating Safety of Asthma Drug Xolair |
